30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Pacira Biosciences Inc (PCRX)

Track

Over the last 90 days, Pacira Biosciences Inc. has seen significant insider selling, with a net value of -$1,090,506.49 and a net insider count of -1. Notably, there were 16 transactions, all of which were sales, totaling $2,238,006.49. The stock price has seen a 3.0% increase over the same period. The company's last earnings report beat expectations by 7.14%.
Stock chart
Ticker: PCRX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Ceesay Abraham
Director
1 sale — total 100,000 USD
Proposed sale 12 Jun 2026
Value US$3,822,307.78 | Price 18.82 | Shares 57,431
Planned sale 11 Jun 2026
Value US$632,944.14 | Price 451.07 | Shares 14,565
Proposed sale 11 Jun 2026
Value US$936,685.80 | Price 15.98 | Shares 14,853
Planned sale 4 Jun 2026
Value US$100,000.00 | Price 22.27 | Shares 1,000
Proposed sale 4 Jun 2026
Value US$100,000.00 | Price 22.27 | Shares 1,000
Planned sale 23 Apr 2026
Value US$325,595.56 | Price 25.16 | Shares 12,941
Proposed sale 23 Apr 2026
Value US$325,576.30 | Price 25.16 | Shares 12,941
Planned sale 22 Apr 2026
Value US$37,515.00 | Price 25.01 | Shares 1,500
Proposed sale 22 Apr 2026
Value US$37,520.50 | Price 25.01 | Shares 1,500
Planned sale 21 Apr 2026
Value US$71,153.45 | Price 25.01 | Shares 2,845
Proposed sale 21 Apr 2026
Value US$71,149.26 | Price 25.01 | Shares 2,845
Planned sale 20 Apr 2026
Value US$193,929.96 | Price 25.14 | Shares 7,714
Proposed sale 20 Apr 2026
Value US$193,912.24 | Price 25.14 | Shares 7,714
Sale 17 Mar 2026
Value US$10,905.00 | Price 21.81 | Shares 500
Proposed sale 17 Mar 2026
Value US$10,905.10 | Price 21.81 | Shares 500
Planned sale 17 Mar 2026
Value US$74,416.02 | Price 22.82 | Shares 3,261
Proposed sale 17 Mar 2026
Value US$74,416.02 | Price 22.82 | Shares 3,261
Planned sale 2 Feb 2026
Value US$269,702.61 | Price 20.53 | Shares 13,137
Planned sale 2 Feb 2026
Value US$269,702.61 | Price 20.53 | Shares 13,137
Proposed sale 2 Feb 2026
Value US$269,702.61 | Price 20.53 | Shares 13,137
Planned sale 2 Feb 2026
Value US$83,240.00 | Price 20.81 | Shares 4,000
Planned sale 2 Feb 2026
Value US$83,240.00 | Price 20.81 | Shares 4,000
Proposed sale 2 Feb 2026
Value US$84,219.34 | Price 21.05 | Shares 4,000
Planned sale 5 Jan 2026
Value US$34,323.84 | Price 24.24 | Shares 1,416
Proposed sale 5 Jan 2026
Value US$34,323.84 | Price 24.24 | Shares 1,416
Planned sale 10 Dec 2025
Value US$228,874.56 | Price 25.14 | Shares 9,104
Proposed sale 10 Dec 2025
Value US$228,912.00 | Price 25.14 | Shares 9,104
Planned sale 9 Dec 2025
Value US$397,876.88 | Price 25.03 | Shares 15,896
Proposed sale 9 Dec 2025
Value US$397,837.02 | Price 25.03 | Shares 15,896
Planned sale 17 Nov 2025
Value US$95,396.40 | Price 24.09 | Shares 3,960
Proposed sale 17 Nov 2025
Value US$95,396.40 | Price 24.09 | Shares 3,960
Planned sale 10 Nov 2025
Value US$266,405.40 | Price 22.09 | Shares 12,060
Proposed sale 10 Nov 2025
Value US$266,405.40 | Price 22.09 | Shares 12,060
Planned sale 4 Sep 2025
Value US$64,005.26 | Price 27.19 | Shares 2,354
Proposed sale 4 Sep 2025
Value US$64,005.26 | Price 27.19 | Shares 2,354
Sale 7 Aug 2025
Value US$116,267.04 | Price 23.67 | Shares 4,912
Proposed sale 7 Aug 2025
Value US$116,278.83 | Price 23.67 | Shares 4,912
Sale 4 Jun 2025
Value US$146,208.16 | Price 26.21 | Shares 5,578
Proposed sale 4 Jun 2025
Value US$146,209.14 | Price 26.21 | Shares 5,579
Sale 4 Jun 2025
Value US$377,226.24 | Price 26.24 | Shares 14,376
Proposed sale 4 Jun 2025
Value US$377,226.24 | Price 26.24 | Shares 14,376
Proposed sale 6 Mar 2025
Value US$11,625.00 | Price 23.25 | Shares 500
Proposed sale 6 Jan 2025
Value US$16,173.60 | Price 18.40 | Shares 879
Planned sale 6 Jan 2025
Value US$16,173.60 | Price 18.40 | Shares 879
Planned sale 13 Dec 2024
Value US$9,880.00 | Price 19.76 | Shares 500
Proposed sale 13 Dec 2024
Value US$9,880.00 | Price 19.76 | Shares 500
Proposed sale 13 Sep 2024
Value US$6,430.00 | Price 12.86 | Shares 500
Planned sale 13 Sep 2024
Value US$6,430.00 | Price 12.86 | Shares 500
Buy 16 Aug 2024
Value US$12,810.00 | Price 12.81 | Shares 1,000
Buy 16 Aug 2024
Value US$20,034.00 | Price 13.25 | Shares 1,512
Buy 14 Aug 2024
Value US$25,800.00 | Price 12.90 | Shares 2,000
Buy 12 Aug 2024
Value US$99,994.40 | Price 12.10 | Shares 8,264
Buy 12 Aug 2024
Value US$16,212.00 | Price 11.58 | Shares 1,400
Buy 12 Aug 2024
Value US$40,834.00 | Price 12.01 | Shares 3,400
Proposed sale 2 Aug 2024
Value US$18,947.25 | Price 20.05 | Shares 945
Planned sale 2 Aug 2024
Value US$18,947.25 | Price 20.05 | Shares 945
Planned sale 2 Jul 2024
Value US$80,117.00 | Price 28.25 | Shares 2,836
Proposed sale 2 Jul 2024
Value US$80,117.00 | Price 28.25 | Shares 2,836
Proposed sale 13 Jun 2024
Value US$28,380.00 | Price 28.38 | Shares 1,000
Planned sale 13 Jun 2024
Value US$28,380.00 | Price 28.38 | Shares 1,000
Proposed sale 13 Jun 2024
Value US$211,487.76 | Price 28.38 | Shares 7,452
Planned sale 13 Jun 2024
Value US$211,487.76 | Price 28.38 | Shares 7,452
Proposed sale 13 Jun 2024
Value US$24,974.40 | Price 28.38 | Shares 880
Planned sale 13 Jun 2024
Value US$24,974.40 | Price 28.38 | Shares 880
Planned sale 12 Jun 2024
Value US$114,018.40 | Price 28.72 | Shares 3,970
Proposed sale 12 Jun 2024
Value US$114,004.69 | Price 28.72 | Shares 3,970
Planned sale 11 Jun 2024
Value US$143,192.84 | Price 28.57 | Shares 5,012
Proposed sale 11 Jun 2024
Value US$143,192.84 | Price 28.57 | Shares 5,012
Sale 8 Mar 2024
Value US$2,754,000.00 | Price 30.60 | Shares 90,000
Sale 7 Mar 2024
Value US$870,598.17 | Price 30.81 | Shares 28,257
Sale 6 Mar 2024
Value US$31,628.22 | Price 29.67 | Shares 1,066
Proposed sale 6 Mar 2024
Value US$3,575,000.00 | Price 29.67 | Shares 120,483
Proposed sale 10 Nov 2023
Value US$875,858.04 | Price 28.25 | Shares 31,000
Planned sale 2 Aug 2023
Value US$17,751.38 | Price 34.88 | Shares 509
Proposed sale 2 Aug 2023
Value US$17,751.58 | Price 34.88 | Shares 509
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-12 2026-06-12 PrS Proposed sale
Ceesay Abraham

Director

Non-Executive Director
57,431
18.82
US$3,822,308 		57,431 18.82 US$3,822,308
2026-06-12 2026-06-11 PlS Planned sale
3.5
RIKER LAUREN

Senior Vice President, Finance

Officer
14,565 +5.3%
451.07
US$632,944 		14,565 +5.3% 451.07 US$632,944
2026-06-11 2026-06-11 PrS Proposed sale
3.5
RIKER LAUREN

Officer

Officer
14,853
15.98
US$936,686 		14,853 15.98 US$936,686
2026-06-05 2026-06-04 PlS Planned sale
3.2
WILLIAMS KRISTEN

Chief Administrative Officer

Officer
1,000 -5.8%
22.27
US$100,000 		1,000 -5.8% 22.27 US$100,000
2026-06-04 2026-06-04 PrS Proposed sale
3.2
WILLIAMS KRISTEN

Officer

Officer
1,000
22.27
US$100,000 		1,000 22.27 US$100,000
2026-04-24 2026-04-23 PlS Planned sale
Cross Shawn

Chief Financial Officer

Officer
12,941 -10.9%
25.16
US$325,596 		12,941 -10.9% 25.16 US$325,596
2026-04-23 2026-04-23 PrS Proposed sale
Cross Shawn

Officer

Officer
12,941
25.16
US$325,576 		12,941 25.16 US$325,576
2026-04-22 2026-04-22 PlS Planned sale
Cross Shawn

Chief Financial Officer

Officer
1,500 -1.4%
25.01
US$37,515 		1,500 -1.4% 25.01 US$37,515
2026-04-22 2026-04-22 PrS Proposed sale
Cross Shawn

Officer

Officer
1,500
25.01
US$37,520 		1,500 25.01 US$37,520
2026-04-22 2026-04-21 PlS Planned sale
Cross Shawn

Chief Financial Officer

Officer
2,845 -2.6%
25.01
US$71,153 		2,845 -2.6% 25.01 US$71,153
2026-04-21 2026-04-21 PrS Proposed sale
Cross Shawn

Officer

Officer
2,845
25.01
US$71,149 		2,845 25.01 US$71,149
2026-04-22 2026-04-20 PlS Planned sale
Cross Shawn

Chief Financial Officer

Officer
7,714 -6.8%
25.14
US$193,930 		7,714 -6.8% 25.14 US$193,930
2026-04-20 2026-04-20 PrS Proposed sale
Cross Shawn

Officer

Officer
7,714
25.14
US$193,912 		7,714 25.14 US$193,912
2026-03-19 2026-03-17 S Sale
3.2
Froimson Mark
Non-Executive Director
500 -2.4%
21.81
US$10,905 		500 -2.4% 21.81 US$10,905
2026-03-19 2026-03-17 PlS Planned sale
3.5
SLONIN JONATHAN

Chief Medical Officer

Officer
3,261 -1.4%
22.82
US$74,416 		3,261 -1.4% 22.82 US$74,416
2026-03-17 2026-03-17 PrS Proposed sale
3.2
Froimson Mark

Director

Non-Executive Director
500
21.81
US$10,905 		500 21.81 US$10,905
2026-03-17 2026-03-17 PrS Proposed sale
3.5
SLONIN JONATHAN

Officer

Officer
3,261
22.82
US$74,416 		3,261 22.82 US$74,416
2026-02-03 2026-02-02 PlS Planned sale
3.2
WILLIAMS KRISTEN

Chief Administrative Officer

Officer
13,137 -9.1%
20.53
US$269,703 		13,137 -9.1% 20.53 US$269,703
2026-02-03 2026-02-02 PlS Planned sale
3.5
RIKER LAUREN

Senior Vice President, Finance

Officer
4,000 -7.1%
20.81
US$83,240 		4,000 -7.1% 20.81 US$83,240
2026-02-03 2026-02-02 PlS Planned sale
3.2
WILLIAMS KRISTEN

Chief Administrative Officer

Officer
13,137 -9.1%
20.53
US$269,703 		13,137 -9.1% 20.53 US$269,703
2026-02-03 2026-02-02 PlS Planned sale
3.5
RIKER LAUREN

Senior Vice President, Finance

Officer
4,000 -7.1%
20.81
US$83,240 		4,000 -7.1% 20.81 US$83,240
2026-02-02 2026-02-02 PrS Proposed sale
3.5
RIKER LAUREN

Officer

Officer
4,000
21.05
US$84,219 		4,000 21.05 US$84,219
2026-02-02 2026-02-02 PrS Proposed sale
3.2
WILLIAMS KRISTEN

Officer

Officer
13,137
20.53
US$269,703 		13,137 20.53 US$269,703
2026-01-06 2026-01-05 PlS Planned sale
3.5
RIKER LAUREN

Senior Vice President, Finance

Officer
1,416 -2.3%
24.24
US$34,324 		1,416 -2.3% 24.24 US$34,324
2026-01-05 2026-01-05 PrS Proposed sale
3.5
RIKER LAUREN

Officer

Officer
1,416
24.24
US$34,324 		1,416 24.24 US$34,324
2025-12-11 2025-12-10 PlS Planned sale
Cross Shawn

Chief Financial Officer

Officer
9,104 -13.9%
25.14
US$228,875 		9,104 -13.9% 25.14 US$228,875
2025-12-10 2025-12-10 PrS Proposed sale
Cross Shawn

Officer

Officer
9,104
25.14
US$228,912 		9,104 25.14 US$228,912
2025-12-11 2025-12-09 PlS Planned sale
Cross Shawn

Chief Financial Officer

Officer
15,896 -22.0%
25.03
US$397,877 		15,896 -22.0% 25.03 US$397,877
2025-12-09 2025-12-09 PrS Proposed sale
Cross Shawn

Officer

Officer
15,896
25.03
US$397,837 		15,896 25.03 US$397,837
2025-11-19 2025-11-17 PlS Planned sale
3.5
SLONIN JONATHAN

Chief Medical Officer

Officer
3,960 -2.2%
24.09
US$95,396 		3,960 -2.2% 24.09 US$95,396
2025-11-17 2025-11-17 PrS Proposed sale
3.5
SLONIN JONATHAN

Officer

Officer
3,960
24.09
US$95,396 		3,960 24.09 US$95,396
2025-11-13 2025-11-10 PlS Planned sale
Cross Shawn

Chief Financial Officer

Officer
12,060 -17.7%
22.09
US$266,405 		12,060 -17.7% 22.09 US$266,405
2025-11-10 2025-11-10 PrS Proposed sale
Cross Shawn

Officer

Officer
12,060
22.09
US$266,405 		12,060 22.09 US$266,405
2025-09-08 2025-09-04 PlS Planned sale
Ceesay Abraham
Non-Executive Director
2,354 -20.7%
27.19
US$64,005 		2,354 -20.7% 27.19 US$64,005
2025-09-04 2025-09-04 PrS Proposed sale
Ceesay Abraham

Director

Non-Executive Director
2,354
27.19
US$64,005 		2,354 27.19 US$64,005
2025-08-11 2025-08-07 S Sale
2.8
BIGAL MARCELO
Non-Executive Director
4,912 -30.1%
23.67
US$116,267 		4,912 -30.1% 23.67 US$116,267
2025-08-07 2025-08-07 PrS Proposed sale
2.8
BIGAL MARCELO

Director

Non-Executive Director
4,912
23.67
US$116,279 		4,912 23.67 US$116,279
2025-06-05 2025-06-04 S Sale
3.5
RIKER LAUREN

Senior Vice President, Finance

Officer
5,578 -8.6%
26.21
US$146,208 		5,578 -8.6% 26.21 US$146,208
2025-06-05 2025-06-04 S Sale
3.2
WILLIAMS KRISTEN

Chief Administrative Officer

Officer
14,376 -8.2%
26.24
US$377,226 		14,376 -8.2% 26.24 US$377,226
2025-06-04 2025-06-04 PrS Proposed sale
3.5
RIKER LAUREN

Officer

Officer
5,579
26.21
US$146,209 		5,579 26.21 US$146,209
2025-06-04 2025-06-04 PrS Proposed sale
3.2
WILLIAMS KRISTEN

Officer

Officer
14,376
26.24
US$377,226 		14,376 26.24 US$377,226
2025-03-06 2025-03-06 PrS Proposed sale
3.4
GAUGLER DARYL

Officer

Officer
500
23.25
US$11,625 		500 23.25 US$11,625
2025-01-06 2025-01-06 PrS Proposed sale
3.5
SLONIN JONATHAN

Officer

Officer
879
18.40
US$16,174 		879 18.40 US$16,174
2025-01-06 2025-01-06 PlS Planned sale
3.5
SLONIN JONATHAN

Chief Medical Officer

Officer
879 -0.9%
18.40
US$16,174 		879 -0.9% 18.40 US$16,174
2024-12-16 2024-12-13 PlS Planned sale
3.4
GAUGLER DARYL

Chief Operating Officer

Officer
500 -0.4%
19.76
US$9,880 		500 -0.4% 19.76 US$9,880
2024-12-13 2024-12-13 PrS Proposed sale
3.4
GAUGLER DARYL

Officer

Officer
500
19.76
US$9,880 		500 19.76 US$9,880
2024-09-13 2024-09-13 PrS Proposed sale
3.4
GAUGLER DARYL

Officer

Officer
500
12.86
US$6,430 		500 12.86 US$6,430
2024-09-13 2024-09-13 PlS Planned sale
3.4
GAUGLER DARYL

Chief Operating Officer

Officer
500 -0.4%
12.86
US$6,430 		500 -0.4% 12.86 US$6,430
2024-08-19 2024-08-16 B Purchase
3.1
Brege Laura
Non-Executive Director
1,000 +6.0%
12.81
US$12,810 		1,000 +6.0% 12.81 US$12,810
2024-08-19 2024-08-16 B Purchase
2.8
BIGAL MARCELO
Non-Executive Director
1,512 +17.5%
13.25
US$20,034 		1,512 +17.5% 13.25 US$20,034
2024-08-14 2024-08-14 B Purchase
3.3
YANG MICHAEL J.
Non-Executive Director
2,000 +38.2%
12.90
US$25,800 		2,000 +38.2% 12.90 US$25,800
2024-08-13 2024-08-12 B Purchase
3.7
Lee Frank D.

Chief Executive Officer

Executive Director
8,264 +8.3%
12.10
US$99,994 		8,264 +8.3% 12.10 US$99,994
2024-08-12 2024-08-12 B Purchase
3.2
Froimson Mark
Non-Executive Director
1,400 +10.7%
11.58
US$16,212 		1,400 +10.7% 11.58 US$16,212
2024-08-12 2024-08-12 B Purchase
2.8
BIGAL MARCELO
Non-Executive Director
3,400 +65.0%
12.01
US$40,834 		3,400 +65.0% 12.01 US$40,834
2024-08-02 2024-08-02 PrS Proposed sale
3.5
SLONIN JONATHAN

Officer

Officer
945
20.05
US$18,947 		945 20.05 US$18,947
2024-08-02 2024-08-02 PlS Planned sale
3.5
SLONIN JONATHAN

Chief Medical Officer

Officer
945 -1.0%
20.05
US$18,947 		945 -1.0% 20.05 US$18,947
2024-07-03 2024-07-02 PlS Planned sale
3.5
SLONIN JONATHAN

Chief Medical Officer

Officer
2,836 -2.9%
28.25
US$80,117 		2,836 -2.9% 28.25 US$80,117
2024-07-02 2024-07-02 PrS Proposed sale
3.5
SLONIN JONATHAN

Officer

Officer
2,836
28.25
US$80,117 		2,836 28.25 US$80,117
2024-06-13 2024-06-13 PrS Proposed sale
3.4
GAUGLER DARYL

Officer

Officer
1,000
28.38
US$28,380 		1,000 28.38 US$28,380
2024-06-13 2024-06-13 PrS Proposed sale
3.2
WILLIAMS KRISTEN

Officer

Officer
7,452
28.38
US$211,488 		7,452 28.38 US$211,488
2024-06-13 2024-06-13 PrS Proposed sale
2.8
HASTINGS PAUL J

Director

Non-Executive Director
880
28.38
US$24,974 		880 28.38 US$24,974
2024-06-13 2024-06-13 PlS Planned sale
3.2
WILLIAMS KRISTEN

Chief Administrative Officer

Officer
7,452 -6.8%
28.38
US$211,488 		7,452 -6.8% 28.38 US$211,488
2024-06-13 2024-06-13 PlS Planned sale
2.8
HASTINGS PAUL J
Non-Executive Director
880 -6.5%
28.38
US$24,974 		880 -6.5% 28.38 US$24,974
2024-06-13 2024-06-13 PlS Planned sale
3.4
GAUGLER DARYL

Chief Operating Officer

Officer
1,000 -0.9%
28.38
US$28,380 		1,000 -0.9% 28.38 US$28,380
2024-06-13 2024-06-12 PlS Planned sale
3.5
RIKER LAUREN

Senior Vice President, Finance

Officer
3,970 -9.4%
28.72
US$114,018 		3,970 -9.4% 28.72 US$114,018
2024-06-12 2024-06-12 PrS Proposed sale
3.5
RIKER LAUREN

Officer

Officer
3,970
28.72
US$114,005 		3,970 28.72 US$114,005
2024-06-13 2024-06-11 PlS Planned sale
3.5
SLONIN JONATHAN

Chief Medical Officer

Officer
5,012 -10.1%
28.57
US$143,193 		5,012 -10.1% 28.57 US$143,193
2024-06-11 2024-06-11 PrS Proposed sale
3.5
SLONIN JONATHAN

Officer

Officer
5,012
28.57
US$143,193 		5,012 28.57 US$143,193
2024-03-08 2024-03-08 S Sale
4.1
PACE GARY W
Non-Executive Director
90,000 -80.3%
30.60
US$2,754,000 		90,000 -80.3% 30.60 US$2,754,000
2024-03-08 2024-03-07 S Sale
4.1
PACE GARY W
Non-Executive Director
28,257 -20.1%
30.81
US$870,598 		28,257 -20.1% 30.81 US$870,598
2024-03-08 2024-03-06 S Sale
4.1
PACE GARY W
Non-Executive Director
1,066 -0.8%
29.67
US$31,628 		1,066 -0.8% 29.67 US$31,628
2024-03-06 2024-03-06 PrS Proposed sale
4.1
PACE GARY W

Board member
120,483
29.67
US$3,575,000 		120,483 29.67 US$3,575,000
2023-11-13 2023-11-10 PrS Proposed sale
3.7
WINSTON ROY

Former Officer

Officer
31,000
28.25
US$875,858 		31,000 28.25 US$875,858
2023-08-04 2023-08-02 PlS Planned sale
3.7
WINSTON ROY

Chief Medical Officer

Officer
509 -1.0%
34.88
US$17,751 		509 -1.0% 34.88 US$17,751
2023-08-02 2023-08-02 PrS Proposed sale
3.7
WINSTON ROY

Officer

Officer
509
34.88
US$17,752 		509 34.88 US$17,752
Explore more

More insider trading research around Pacira Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America